Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dare Bioscience Inc
(NQ:
DARE
)
0.5120
-0.0380 (-6.91%)
Streaming Delayed Price
Updated: 2:43 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dare Bioscience Inc
< Previous
1
2
3
Next >
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
Today 13:53 EDT
DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: Dare Bioscience Q4 Earnings
Today 10:25 EDT
Via
Benzinga
Earnings Scheduled For March 28, 2024
Today 5:24 EDT
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Dare Bioscience Earnings Preview
March 27, 2024
Via
Benzinga
Earnings Outlook For Dare Bioscience
November 08, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
August 09, 2023
Via
Benzinga
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
February 21, 2024
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 01, 2024
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Via
InvestorPlace
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
December 20, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
Recap: Dare Bioscience Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
May 10, 2023
Via
Benzinga
Earnings Preview: Dare Bioscience
March 29, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Dare Bioscience: Here's What You Need To Know
December 13, 2022
Via
Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
December 07, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 20, 2023
Via
Benzinga
Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause
October 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 31, 2023
On Monday, 27 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 03, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 02, 2023
Via
Benzinga
Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms
January 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 14, 2022
Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options.
Via
Benzinga
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
October 26, 2022
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...
Via
TheNewswire.com
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
October 26, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Can This Company's Birth Control Patch Disrupt The Contraceptive Market?
October 25, 2022
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.